सामग्री को निकलें
IN
BIOSPHERE-AIएक पौधा। एक पूर्वी मिशन।

← All markets

East Asia · Japan

What does it take to sell cosmetics in Japan? Entry route, responsibility, labeling

No pre-market approval for cosmetics: the licensed MAH files a 化粧品製造販売届 (notification) pe…; Responsible person: A Japan-licensed 製造販売業者 (Marketing Authorization Holder) mu…; Labeling: Full ingredient list in Japanese using JCIA 表示名称 ….

Latest change 2025-05-21 — PMD Act amendment (Act No. 37 of 2025) promulgated and phased in from 2025-11-20 and 2026-05-01, tightening MAH governance, quality and supply obligations (largely pharma-focused); separately MHLW's 2025-03-10 notice rewrote the 特記表示 (highlighted-ingredient) rules so that the ingredient's purpose must be stated. Source

Factory-side digest; the official text prevails; not legal advice.

Authority
Ministry of Health, Labour and Welfare (MHLW) with PMDA; prefectural governments issue licences
Main regulation
Act No. 145 of 1960 (renamed PMD Act 2014); latest amendment Act No. 37 of 2025 · Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (PMD Act)
In force
1961-02-01
Market entry
No pre-market approval for cosmetics: the licensed MAH files a 化粧品製造販売届 (notification) per product before sale, whereas products with medicinal claims are 医薬部外品 (quasi-drugs) needing MHLW approval.
Responsible person
A Japan-licensed 製造販売業者 (Marketing Authorization Holder) must hold the product notification and bear full responsibility, and imported goods also need a licensed 製造業者 for labelling/storage.
Safety file
No statutory PIF; the MAH must ensure conformity with 化粧品基準 and the GQP/GVP ordinances and keep quality and safety records.
Labeling
Full ingredient list in Japanese using JCIA 表示名称 (mandatory since 2001-04-01) plus product name, MAH name/address, contents and lot; a highlighted ingredient (特記表示) must state its purpose (2025-03-10 notice); no fragrance-allergen labelling rule in force.
Animal testing
No statutory ban and no requirement for cosmetics; quasi-drug approvals may still rely on animal data.
Ingredient lists
化粧品基準 (Standards for Cosmetics, MHW Notification No. 331 of 2000, last amended 2024-07-12): negative list plus positive lists for preservatives, UV filters and tar colours.
Notes
Consultancy claims that Japan will mandate fragrance-allergen labelling from May 2026 could not be verified on MHLW's site and should be treated as unconfirmed; MHLW also introduced electronic export certificates for cosmetics on 2026-07-27 (ChemLinked).
Look up this inventory here
日本 · Standards for Cosmetics — appended tables
Official text
https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/keshouhin/index.html

Changes 2025–2026

  1. Japan promulgates PMD Act amendment (Act No. 37 of 2025)

    Phased in from 2025-11-20 and 2026-05-01, the amendment strengthens MAH quality/safety governance and supply obligations; the cosmetics-specific 2025 change was MHLW's 2025-03-10 notice rewriting the 特記表示 highlighted-ingredient rules to require the ingredient's purpose on packs and ads. Source

FAQ

Does Japan require notification or registration before sale?

No pre-market approval for cosmetics: the licensed MAH files a 化粧品製造販売届 (notification) per product before sale, whereas products with medicinal claims are 医薬部外品 (quasi-drugs) needing MHLW approval.

Is a local responsible person mandatory in Japan?

A Japan-licensed 製造販売業者 (Marketing Authorization Holder) must hold the product notification and bear full responsibility, and imported goods also need a licensed 製造業者 for labelling/storage.

What are the labeling requirements in Japan?

Full ingredient list in Japanese using JCIA 表示名称 (mandatory since 2001-04-01) plus product name, MAH name/address, contents and lot; a highlighted ingredient (特記表示) must state its purpose (2025-03-10 notice); no fragrance-allergen labelling rule in force.

What changed recently in Japan cosmetic regulation?

2025-05-21 PMD Act amendment (Act No. 37 of 2025) promulgated and phased in from 2025-11-20 and 2026-05-01, tightening MAH governance, quality and supply obligations (largely pharma-focused); separately MHLW's 2025-03-10 notice rewrote the 特記表示 (highlighted-ingredient) rules so that the ingredient's purpose must be stated.

Source: 12345

Related buyer questions

Entering Japan? Send the product type and we reply with the factory-side document list and lead time. Send an inquiry